Data (n = 34,001) were collected by annual assessments questionnaires. In 2002, only 16% of the OMT patients received buprenorphine as their maintenance medication.
By 2011 this percentage had increased significantly (p < .001) to 50.3%. In the same period the number of patients more than tripled (from 1,984 to 6,640, p < .001), and programme attrition rates decreased (p = .020). T
his relatively rapid shift is a part of the increasing reliance of addiction medicine upon a range of medications administered by different routes which has not been previously charted within a national treatment programme.
- Forfattere: Marianne Riksheim, Michael Gossop, Thomas Clausen
- Publisert: Journal of Substance Abuse Treatment, Volume 46, Issue 3, March 2014, Pages 291–294 - DOI: 10.1016/j.jsat.2013.10.006